[go: up one dir, main page]

ES263124A1 - A process for the manufacture of benzodiazepine derivatives - Google Patents

A process for the manufacture of benzodiazepine derivatives

Info

Publication number
ES263124A1
ES263124A1 ES0263124A ES263124A ES263124A1 ES 263124 A1 ES263124 A1 ES 263124A1 ES 0263124 A ES0263124 A ES 0263124A ES 263124 A ES263124 A ES 263124A ES 263124 A1 ES263124 A1 ES 263124A1
Authority
ES
Spain
Prior art keywords
amino
substituent
nitro
halogeno
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0263124A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES263124A1 publication Critical patent/ES263124A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/42Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrolysis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/16Saturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/74Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/26Preparation from compounds already containing the benzodiazepine skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compounds of the general formula <FORM:0972961/C1/1> (wherein R represents an optional alkyl, alkenyl or aralkyl substituent, R1 represents an optional alkyl substituent, R2 represents an optional alkyl, alkoxy, trifluoromethyl or halogeno substituent, R3 represents an optional trifluoromethyl, alkyl, alkoxy, alkylthio, hydroxyalkylthio, halogeno, nitro, amino, alkylsulphinyl, alkylsulphonyl, hydroxy or acylamino substituent and R4, which can only be present when R3 is other than a trifluoromethyl substituent, represents an optional alkyl, alkoxy, alkylthio, hydroxy-alkylthio, halogeno, nitro, amino, alkylsulphinyl, alkylsulphonyl, hydroxy or acylamino substituent, and the broken lines denote the bonds to the optional substituents) are prepared by reacting a 2-aminobenzophenone betaoxime of the general formula <FORM:0972961/C1/2> (wherein R30 and R40 have any of the values accorded to R3 and R4 except amino) with an a -halogenoacyl halide of the general formula <FORM:0972961/C1/3> (wherein X and Y represent halogeno substituents) in the presence of more than one mol of an acid-binding agent and, in the case where R30 and R40 were absent in the starting material, subjecting the benzodiazepine formed to one or more of the steps nitration, reduction of the nitro group and acylation of the resulting amino group where it is desired to introduce a nitro, amino or acylamino group or, in the case where one or both or R30 and R40 were nitro groups in the starting material, subjecting the benzodiazepine formed to one or both of the steps of reduction of the nitro group or groups and acylation of the resulting amino group or groups where one or two amino or acylamino groups is or are required in the product. The reaction proceeds through an intermediate acyl amide which can be isolated when the reaction is carried out stepwise using one mol of the acidbinding agent in the initial step. The preferred acid-binding agent is sodium hydroxide. 2-Chloroacetamido -5- chlorobenzophenone betaoxime is prepared by condensing 2-amino-5-chlorobenzophenone betaoxime with chloroacetyl chloride in the presence of approximately 1 mol of sodium hydroxide. Specification 972,968 is referred to.
ES0263124A 1959-12-10 1960-12-09 A process for the manufacture of benzodiazepine derivatives Expired ES263124A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85856459A 1959-12-10 1959-12-10
US260560A 1960-01-15 1960-01-15
US2468660A 1960-04-26 1960-04-26
US3873260A 1960-06-27 1960-06-27

Publications (1)

Publication Number Publication Date
ES263124A1 true ES263124A1 (en) 1961-06-01

Family

ID=27485190

Family Applications (2)

Application Number Title Priority Date Filing Date
ES0263123A Expired ES263123A1 (en) 1959-12-10 1960-12-09 A PROCEDURE FOR THE MANUFACTURE OF 1,4-BENZODIAZEPINE DERIVATIVES
ES0263124A Expired ES263124A1 (en) 1959-12-10 1960-12-09 A process for the manufacture of benzodiazepine derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES0263123A Expired ES263123A1 (en) 1959-12-10 1960-12-09 A PROCEDURE FOR THE MANUFACTURE OF 1,4-BENZODIAZEPINE DERIVATIVES

Country Status (11)

Country Link
BE (4) BE598012A (en)
BR (1) BR6024755D0 (en)
CH (9) CH411910A (en)
CY (1) CY324A (en)
DE (5) DE1288610B (en)
ES (2) ES263123A1 (en)
GB (13) GB972966A (en)
MY (1) MY6500178A (en)
NL (2) NL6412251A (en)
OA (7) OA00816A (en)
SE (2) SE310887B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795231C3 (en) * 1963-05-29 1978-07-13 American Home Products Corp., New York, N.Y. (V.St.A.) Process for the preparation of 5-aryl-1,2-dihydro -3H-1,4-benzodiazepin-2-one-4-oxides
GB1333501A (en) * 1971-03-05 1973-10-10 Ravizza Spa Process for the preparation of 7-chlorobenzodiazepine de rivatives
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
JP2005503356A (en) * 2001-06-07 2005-02-03 ニューロ3デー Cyclic nucleotide phosphodiesterase inhibitors, their production and use
CA2784937A1 (en) * 2002-05-24 2003-12-04 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2893992A (en) * 1959-07-07 I ii i i

Also Published As

Publication number Publication date
MY6500178A (en) 1965-12-31
GB972962A (en) 1964-10-21
DE1290143B (en) 1969-03-06
SE318283B (en) 1969-12-08
OA00953A (en) 1968-03-22
NL6412250A (en) 1966-01-25
ES263123A1 (en) 1961-06-01
GB972972A (en) 1964-10-21
OA00959A (en) 1968-03-22
SE310887B (en) 1969-05-19
OA00816A (en) 1967-11-15
GB972969A (en) 1964-10-21
BE598012A (en) 1961-06-09
BE598015A (en) 1961-06-09
OA02385A (en) 1970-05-05
DE1288609B (en) 1969-02-06
CH418341A (en) 1966-08-15
CH396016A (en) 1965-07-31
GB972970A (en) 1964-10-21
OA02384A (en) 1970-05-05
CH408029A (en) 1966-02-28
CH408940A (en) 1966-03-15
GB972976A (en) 1964-10-21
DE1445073A1 (en) 1968-10-31
CY324A (en) 1965-11-03
BR6024755D0 (en) 1973-05-24
GB972964A (en) 1964-10-21
CH411910A (en) 1966-04-30
GB972966A (en) 1964-10-21
GB972961A (en) 1964-10-21
CH414652A (en) 1966-06-15
GB972963A (en) 1964-10-21
GB972965A (en) 1964-10-21
DE1288610B (en) 1969-02-06
CH418342A (en) 1966-08-15
CH414653A (en) 1966-06-15
DE1445908A1 (en) 1969-04-17
CH408045A (en) 1966-02-28
BE598013A (en) 1961-06-09
BE598008A (en) 1961-06-09
GB972968A (en) 1964-10-21
OA00958A (en) 1968-03-22
GB972967A (en) 1964-10-21
OA00817A (en) 1967-11-15
GB972973A (en) 1964-10-21
NL6412251A (en) 1966-01-25

Similar Documents

Publication Publication Date Title
GB1059146A (en) 1-aryl-3-anilino-5-pyrazolone derivatives and their use in colour development processes
ES263124A1 (en) A process for the manufacture of benzodiazepine derivatives
GB965009A (en) New 2,3-dimercapto-quinoxalines
GB1458377A (en) Pyrazolotriazoles
GB1531161A (en) Process for the preparation of 2-(4&#39;-amino-phenyl)-6-amino-benzimidazole
ATE221872T1 (en) PRODUCTION OF TRI-IODO-BENZENE COMPOUNDS
GB1136933A (en) Process for the production of tetra--‡-substituted anthraquinone derivatives
GB866843A (en) Sulphonamidopyrimidines
GB1102439A (en) Azo dyestuffs containing a quaternised triazolium ring and process for their production
ES477727A1 (en) Mono- and dinitrodihydroxydiazobenzenes
ES450380A1 (en) Indaneacetic acid derivatives
GB1138530A (en) 2-phenylamino-2-oxazolines and their production
GB1098736A (en) New anthraquinone dyestuffs and processes for their manufacture and use
GB1439838A (en) Process for the preparation of diphenylamine and substituted derivatives thereof
ES477191A1 (en) Process for the preparation of aromatic (b)-fused pyridines and novel thieno(b)pyridines.
GB1128217A (en) Sulphonyl phenols and thiophenols and their use as herbicides
US2840567A (en) 1-(p-aminophenyl)-3-aminopyrazolines and process
GB1379428A (en) Unsaturated amides containing tertiary amino groups
GB1374401A (en) Process for the production of alpha-imino-nitriles
GB1386326A (en) Process for the production of quinazolines
JPS54112861A (en) 1,2-substituted-4,5-dicyanoimidazole and its preparation
ES441620A1 (en) Procedure for preparing 1-dimetilcarbamil-3-branched alcoholic-1,2,4-triazol-5-il-sulfonamidas substituted in n. (Machine-translation by Google Translate, not legally binding)
GB1185046A (en) Process for the Manufacture of Amine Derivatives
GB681095A (en) Propellent explosives having a high deflagration temperature
ES325546A1 (en) Procedure for the preparation of new biologically active derivatives of fenantridone. (Machine-translation by Google Translate, not legally binding)